A Study of Lung Cancer Risk
ARISE: Assessing Lung Cancer Risk in Never-Smoking Women
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 40 Years to 74 Years
- Sex
- All sexes
- Healthy volunteers
- Accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
The researchers are doing this study to learn more about factors that may increase the risk of lung cancer in people who have never smoked. This information may help predict which people who have never smoked may be more likely to get lung cancer.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Official eligibility criteria
Criteria: * Female at birth * Age 40-74 years * No smoking history * Participants must be never-smokers, defined as having smoked \<100 cigarettes in their lifetime * Documentation of disease - case patients o Case patients must have pathologically confirmed primary lung adenocarcinoma. New and prevalent cases will be eligible. Case patients with a history of prior non-lung cancer will be eligible for the study unless actively being diagnosed or treated for another form of cancer at the time of enrollment. * Criteria for control participants * Control participants must have no personal history of lung cancer, symptoms suspicious for lung cancer, or suspicious pulmonary nodules. Participants recruited as controls and found on imaging to have lesions suspicious for lung cancer will be excluded from analysis and followed prospectively. Data regarding these participants will be reported in a sensitivity analysis. Additional control participants will be recruited to ensure balanced age- and race-matched enrollment by frequency matching. Control participants with a history of prior non-lung cancer will be eligible for the study unless actively being diagnosed or treated for another form of cancer at the time of enrollment.
Study sites (7)
NJ
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities) · Basking Ridge, NJ 07920Alexis Chidi, MD, PhD · Study contact · 929-829-0677More trials in Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities) · Middletown, NJ 07748Alexis Chidi, MD, PhD · Study contact · 929-829-0677More trials in Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities) · Montvale, NJ 07645Alexis Chidi, MD, PhD · Study contact · 929-829-0677More trials in Montvale
NY
- Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) · Commack, NY 11725Alexis Chidi, MD, PhD · Study contact · 929-829-0677More trials in Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities) · Harrison, NY 10604Alexis Chidi, MD, PhD · Study contact · 929-829-0677More trials in Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) · New York, NY 10065Alexis Chidi, MD, PhD · Study contact · 929-829-0677More trials in New York
- Memorial Sloan Kettering Nassau (All Protocol Activities) · Uniondale, NY 11553Alexis Chidi, MD, PhD · Study contact · 929-829-0677More trials in Uniondale